Simulations Plus (NASDAQ:SLP) Coverage Initiated by Analysts at Stephens

Analysts at Stephens initiated coverage on shares of Simulations Plus (NASDAQ:SLP) in a research report issued to clients and investors on Friday,Briefing.com Automated Import reports. The firm set an “overweight” rating and a $39.00 price target on the technology company’s stock. Stephens’ price objective points to a potential upside of 31.27% from the company’s current price.

Other analysts have also recently issued research reports about the company. BTIG Research decreased their target price on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday, October 24th. StockNews.com lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. KeyCorp assumed coverage on shares of Simulations Plus in a research report on Monday, July 29th. They issued an “overweight” rating and a $47.00 price objective for the company. Finally, William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $51.40.

Simulations Plus Stock Performance

SLP opened at $29.71 on Friday. The firm has a market cap of $596.28 million, a price-to-earnings ratio of 60.63 and a beta of 0.71. The firm’s 50-day simple moving average is $31.40 and its 200-day simple moving average is $39.11. Simulations Plus has a twelve month low of $27.22 and a twelve month high of $51.22.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company’s revenue was up 19.9% on a year-over-year basis. During the same quarter last year, the business posted $0.18 earnings per share. As a group, sell-side analysts anticipate that Simulations Plus will post 1.12 EPS for the current fiscal year.

Insider Activity

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction on Friday, November 1st. The shares were sold at an average price of $27.66, for a total transaction of $553,200.00. Following the completion of the sale, the director now owns 3,462,584 shares in the company, valued at approximately $95,775,073.44. The trade was a 0.57 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last quarter, insiders have sold 60,750 shares of company stock valued at $1,905,655. 20.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Simulations Plus

Several institutional investors have recently modified their holdings of SLP. Azzad Asset Management Inc. ADV increased its holdings in shares of Simulations Plus by 3.6% in the second quarter. Azzad Asset Management Inc. ADV now owns 8,007 shares of the technology company’s stock worth $389,000 after acquiring an additional 280 shares in the last quarter. InTrack Investment Management Inc raised its holdings in Simulations Plus by 1.1% during the 2nd quarter. InTrack Investment Management Inc now owns 31,665 shares of the technology company’s stock worth $1,540,000 after buying an additional 330 shares during the period. First Horizon Advisors Inc. raised its holdings in Simulations Plus by 82.6% during the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock worth $26,000 after buying an additional 370 shares during the period. Chatham Capital Group Inc. boosted its holdings in shares of Simulations Plus by 1.3% in the second quarter. Chatham Capital Group Inc. now owns 34,554 shares of the technology company’s stock valued at $1,680,000 after buying an additional 450 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Simulations Plus by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company’s stock valued at $311,000 after buying an additional 456 shares during the period. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.